Blueprint vs Emosapien

Depends on the job. Blueprint is a measurement-based-care platform: a deep assessment library (PHQ-9, GAD-7, PCL-5, AUDIT, EDE-Q and more), auto-scoring, outcomes dashboards, and payer-ready reporting. Emosapien is AI co-therapy: a Co-Therapy Agent that participates during the session with modality-aligned prompts, an Engagement Agent that runs the week between sessions, AI-drafted progress notes, and treatment-plan automation. Emosapien also covers PHQ-9, GAD-7, and ORS as part of the Engagement Agent. If MBC reporting is the single most important capability, Blueprint is stronger on assessment library breadth. If you want AI inside the session and across the full week, Emosapien is the broader pick.

No. Blueprint is built around measurement-based care: assessments delivered to clients between sessions, scored automatically, plotted against trends in the clinician dashboard. The clinician runs the session itself unaided by Blueprint. Emosapien is built differently: the Co-Therapy Agent listens during the session and surfaces modality-aligned cues (CBT reframes, ACT values prompts, DBT distress-tolerance moves) tied to the active treatment goal, and the progress note is drafted from that clinical context.

For PHQ-9, GAD-7, and ORS, yes. The Engagement Agent auto-schedules those measures between sessions, scores them on submission, plots trends against the treatment-plan objective, and surfaces the change in the pre-session brief. Blueprint covers a wider assessment library (PCL-5, AUDIT, EDE-Q, Y-BOCS, BSL-23 and more) and offers deeper payer-ready outcomes reporting for value-based contracts. If your MBC programme depends on assessment breadth or payer reporting, Blueprint is the stronger MBC tool; if PHQ-9 / GAD-7 / ORS plus continuous client engagement is enough, Emosapien covers it natively. The practical MBC guide walks through what a working programme looks like.

Three structural things. (1) Active in-session co-therapy: the Co-Therapy Agent participates during the session with modality-aligned intervention prompts, not just assessment scores between sessions. (2) AI-drafted progress notes: SOAP, DAP, BIRP, GIRP, PIE drafted from the session, not a separate documentation workflow. (3) Treatment-plan automation: a structured plan with SMART objectives that updates from session notes automatically. Blueprint is a measurement-based-care platform; these are different jobs.

Emosapien is publicly priced: Free (10 sessions per month, no credit card), Starter ($29/seat/month annual), Professional ($79/seat/month annual, includes the Co-Therapy and Engagement Agents), Enterprise (custom). Blueprint pricing has historically been quote-driven for groups and requires a conversation with their sales team for current numbers; their solo-clinician tier is publicly priced. Verify current Blueprint pricing directly on their website before committing. See Emosapien pricing for full plan limits.

Yes, and some practices do. Blueprint handles deep MBC and payer reporting; Emosapien handles in-session co-therapy, progress notes, treatment-plan automation, and between-session client engagement. They overlap on PHQ-9 / GAD-7 / ORS scheduling, so pick one place to run those measures to avoid duplicate delivery to clients. Most practices that evaluate Emosapien after Blueprint do so because they want AI inside the session or want to consolidate the between-session client surface into one app.